Welcome to our dedicated page for MEDICAL CARE TECHS news (Ticker: MDCE), a resource for investors and traders seeking the latest updates and insights on MEDICAL CARE TECHS stock.
Medical Care Technologies Inc. develops and commercializes artificial intelligence applications across consumer software, imaging analysis, healthcare-oriented pre-screening and collectibles authentication. News about MDCE centers on its AI technology stack, including Snapshot Recipes, a mobile recipe application with AI-generated food and beverage content, and Real Game Used, a subsidiary developing a patent-pending AI authentication platform for sports memorabilia.
Company updates also cover AI imaging initiatives for dermatological analysis, wellness monitoring, product verification and automated quality control, as well as capital and asset-monetization activity through Infinite Auctions. Recurring announcements describe product redesigns, commercialization pathways, subsidiary activity, mobile-app user growth initiatives, and enterprise API or visual analytics use cases.
Medical Care Technologies (MDCE) has launched the first presentation of its StrainScan Pro AI vision platform in restaurant service, moving from a planning phase on September 18, 2026 to an executed kitchen workflow demonstration.
The software, already used in agricultural quality applications, is now shown to restaurant operators as an iPad Air-based inspection pipeline across three stations: receiving, staging, and pass. Each station uses the same sequence of image capture, contextual indexing, visual analysis versus expected appearance, and exception routing. The company stresses that this is a first-time vertical demonstration and not a commercial contract award, and that StrainScan Pro is an enterprise visual analysis tool rather than a medical device.
Medical Care Technologies (MDCE) is preparing its first StrainScan Pro demonstration tailored for restaurant service, adapting its existing enterprise AI vision platform from agricultural use to kitchen workflows. The demo will follow a three-station inspection path covering receiving, staging/prep hold, and the pass station, where incoming produce, prepped items, and finished plates are visually analyzed on-device using iPad Air. Each capture is indexed to station and lot, run through category-specific visual analysis modules, and exceptions are routed for hold or secondary review to help reduce product waste, remakes, and margin loss. The company stresses this is a demo in preparation, not a commercial contract.
Medical Care Technologies (MDCE) reports receipt of its first human volunteer image datasets for internal testing of the MDCE Melanoma Scan Beta platform. This follows the August 31 call for volunteers and marks a move beyond earlier work that relied on public dermatology archives such as HAM10000, ISIC collections, and TCIA melanoma cohorts. The new images introduce real‑world conditions, including varied lighting, device types, distances, angles, image quality, and skin appearances. The datasets will be used to evaluate image intake, body‑map organization, and longitudinal comparison of the same skin areas over time. The AI‑assisted application remains in beta, has no regulatory clearance, and is not intended for diagnosis, treatment, or disease prevention.
Medical Care Technologies (MDCE) detailed the four-stage on-device visual inspection pipeline used by its StrainScan Pro AI vision software on iPad Air for agricultural and foodservice quality analysis.
The workflow consists of image acquisition, where operators capture controlled visual samples of produce; contextual indexing, which links images to metadata such as crop module, lot, station, time, and location; differential visual analysis, comparing current samples to category expectations and prior images; and exception routing, which can direct suspect product to hold, secondary review, or rejection at the inspection point.
The company positions this on-device approach as a way to enable earlier visual defect detection in markets it cites as multi-trillion dollar agriculture and foodservice sectors, while clarifying that the announcement is technical, not a commercial contract, and that StrainScan Pro is not a medical device.
Medical Care Technologies (MDCE) announced that subsidiaries Infinite Auctions and Real Game Used have executed a transactional agreement with Fanatics / Topps to supply and authenticate game-worn sports memorabilia for Topps trading card products.
Infinite Auctions will sell game-worn items to Topps, while Real Game Used will provide AI-enhanced photo-match authentication to support product integrity. Fanatics reported about $8.1 billion in 2024 revenue, with its Topps-powered collectibles division at about $1.6 billion and expected by the company to approach $3 billion in 2026. MDCE states the agreement does not guarantee specific revenue or volume and highlights ongoing development of its AI vision projects, including Melanoma Scan Beta, a wound care app, and StrainScan Pro.
Medical Care Technologies (MDCE) reported progress on its StrainScan Pro platform by moving its foodservice application into custom demonstrations for commercial kitchens and multi-unit operators.
The AI vision software, already positioned for both agriculture and foodservice, now follows its farm-side demo work with kitchen-focused sessions built around receiving checks, line-level visual review, and consistency monitoring across single or multiple sites. StrainScan Pro runs on portable iPad Air devices, aiming to bring visual quality analysis from packing environments into kitchens in the global restaurant and foodservice market, which is estimated near $4 trillion. The company emphasized that this update reflects platform advancement rather than any commercial contract award.
Medical Care Technologies (MDCE) is configuring its StrainScan Pro AI vision platform for high-value, highly perishable crops including leafy greens, berries, tomatoes and tree fruit. The software is designed for on-device analysis and portable deployment on iPad Air hardware, supporting inspection in fields, on packing lines and at post-harvest checkpoints.
The company is building crop-specific visual modules tuned to traits that affect grade, shelf life and rejection risk, such as surface defects, color inconsistency, bruising and wilting. Development priorities are based on feedback from early operator sessions and are focused on crops where visual defects and spoilage can rapidly destroy value. This update reflects ongoing configuration work and is not a commercial contract award.
Medical Care Technologies (MDCE) reports that initial StrainScan Pro demonstrations with agricultural operators are underway and generating feedback that is directly shaping the platform’s next development cycle.
The proprietary AI vision software is built for agricultural and foodservice use and is designed for portable deployment on iPad Air devices to support visual quality analysis in the field, at packing points, and other production decision points. Early demos have focused on produce inspection, visual grading, consistency checks, and early detection of quality issues. Operator input is being used to add workflow depth, speed on-device review, clarify comparison steps, and create additional quality-check paths. The company positions StrainScan Pro as a scalable visual quality platform for a global agricultural market often estimated at $4.8–$5 trillion in gross production value.
Medical Care Technologies (MDCE) on September 8, 2026 highlighted a multi-platform AI business spanning health, enterprise imaging, consumer apps, and revenue-generating subsidiaries.
The company is advancing Melanoma Scan Beta, an AI-assisted skin imaging and body-map monitoring app that remains in beta, lacks regulatory clearance, and is not intended for diagnosis or treatment. Work includes internal testing on public dermatology datasets and volunteer image intake. StrainScan Pro targets agriculture and foodservice quality uses, with custom demos for enterprise clients and planned portable deployment on iPad Air. Snapshot Recipes is a live consumer mobile app, while subsidiaries Infinite Auctions and Real Game Used operate in online auctions and memorabilia authentication.
Medical Care Technologies (MDCE) has opened volunteer intake for the first human-submitted image cohort supporting its MDCE Melanoma Scan Beta testing initiative, following an earlier August 31, 2026 announcement.
The project moves beyond public cancer imaging datasets such as HAM10000, ISIC Archive collections, and TCIA melanoma cohorts by adding real-world user images. Volunteer images are expected to be used only for internal model evaluation, workflow and intake testing, body-map organization review, and longitudinal comparison functions. The company emphasizes that this is a development and testing process, not a clinical diagnosis program, and the beta platform has not received regulatory clearance and is not intended to diagnose, treat, cure, or prevent disease.